Código QR

Comparison of efficacy and safety between TIcagrelor and clopidogrel in Chinese patients with acute coronary syndrome (COSTIC study)

Background: Ticagrelor is recommended as the preferred antiplatelet agent for patients with acute coronary syndrome (ACS), which is controversial in East Asians, Chinese patients in particular. This study aimed to compare the efficacy and safety of ticagrelor vs. clopidogrel in Chinese ACS patients...

Descrición completa

Gardado en:
Principais autores: Man Huang, Yang Sun, Ke Li, Ting Yu, Hu Zhao, Min Tao, Xiuli Song, Linlin Wang, Xin Xu, Yanghui Chen, Guanglin Cui, Hu Ding, Jiangtao Yan, Jiangang Jiang, Hesong Zeng, Yan Wang, Xiaoqing Shen, Hong Wang, Dao Wen Wang
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2026-02-01
Series:International Journal of Cardiology: Heart & Vasculature
Assuntos:
Ticagrelor
Clopidogrel
Acute coronary syndrome
Percutaneous coronary intervention
Clinical endpoints
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2352906726000023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares